XT
CMPX icon

XTX Topco’s Compass Therapeutics CMPX Stock Holding History

XTX Topco’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$371K Sell
70,121
-45,513
-39% -$263K 0.01% 2294
2025
Q4 		$621K Buy
115,634
+98,684
+582% +$456K 0.02% 1408
2025
Q3 		$59.3K Sell
16,950
-15,465
-48% -$48.8K ﹤0.01% 2139
2025
Q2 		$84.3K Buy
+32,415
New +$66.8K ﹤0.01% 1915
2025
Q1 		– Sell
-52,754
Closed -$76.5K – 2499
2024
Q4 		$76.5K Buy
52,754
+32,533
+161% +$54K 0.01% 1820
2024
Q3 		$37.2K Buy
+20,221
New +$25.2K ﹤0.01% 1740
2023
Q3 		– Sell
-10,992
Closed -$35K – 1613
2023
Q2 		$35K Buy
+10,992
New +$34.5K 0.01% 1284

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM